drugset / Trial / NCT04879823

Post-operative Course of Dexamethasone to Reduce Tonsillectomy Morbidity

NCT04879823

Phase 3 Terminated 222 enrolled David Chi, MD
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The goal of this study is determine if an oral systemic course of steroids is a safe and effective option in lowering pain and complications following adenotonsillectomy in various pediatric age groups. A double blind, placebo-controlled randomized clinical trial of steroids (dexamethasone) versus placebo postoperatively will be performed. Investigators will determine if there is a difference in post-operative pain and complications between groups.

Timeline

Start
2021-08-05
Primary completion
2023-07-11
Completion
2023-07-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 0.5 mg/kg Oral
Background Acetaminophen Small molecule 15 mg/kg
Background Ibuprofen Small molecule 10 mg/kg

Indications

No indication recorded.